Cancer Panel Testing Services

CLIA Level Sequencing

Cancer Panels Screening

MCL offers diagnostic tests for major cancers

Macrogen Corp. is a CLIA certified laboratory that offers cancer panel testing services to North American hospitals and patients. Cancer panels are highly advanced DNA screenings that identify specific genes and genetic mutations, in a patient’s genome, that are related to major cancers. These panels use Next Generation Sequencing technology, which make it possible to process, sequence, and analyze large volumes of genes and long strands of genetic code. With genome sequencing, physicians can individualize treatment plans for a specific patient’s needs.

Benefits of Cancer Panels

Cancer panels examine our complex genetic information and provide extremely detailed and patient-oriented data, regarding the drivers of major cancers. Panels have the potential to uncover advanced genetic diagnoses, and provide prevention strategies and individualized courses of treatments. Macrogen’s cancer panels provide:

  • Most accurate diagnoses through Next Generation Sequencing under our CLIA license.
  • Analyses based on ACMG*-recommended genes, to offer patients more credible data.
  • Coverage of the most major cancers (Breast Cancer, Pancreatic Cancer, Colon Cancer, Ovarian Cancer, Uterine Cancer, Renal Cancer, Endocrine Cancer, Kidney Cancer, Parathyroid Cancer, Brain Cancer, and Eye Cancer)

img-cancel-panel

Our panels use ACMG recommended genes for cancers

img-cancel-panel2

Our panel tests major cancers. (Breast Cancer, Pancreatic Cancer, Colon Cancer, Ovarian Cancer, Uterine Cancer, Renal Cancer, Endocrine Cancer, Kidney Cancer, Parathyroid Cancer, Brain Cancer, and Eye Cancer)

* American College of Medical Genetics and Genomics

 

Contact Us about this service.